Drug screening technologies are experimental and computational strategies used to identify small molecules or chemical probes that modulate a defined molecular target, signaling pathway, cellular phenotype, disease model, or patient-derived response profile. High-throughput screening tests many compounds in miniaturized assay formats, while quantitative high-throughput screening tests compounds across concentration ranges so that potency and efficacy can be inferred from concentration-response behavior rather than from a single-point signal. The core biological function of a drug-screening strategy is to connect compound exposure with measurable pathway activity, target modulation, cell-state change, viability, cytotoxicity, morphology, or disease-relevant phenotype. Assay performance must be evaluated before screening because hit identification depends on the separation between positive and negative controls, control variability, plate effects, outliers, and the statistical framework
Drug Screening Technologies
Drug Screening technology is a method of efficiently and systematically testing large numbers of samples to find targets with specific properties or functions. In biology and drug research, screening technology is widely used in drug discovery, gene screening, protein interaction research and other fields. Common screening technologies include high-throughput screening (HTS), genomics, proteomics, chemical biology, etc.
Related Experimental Schemes
